LOW-FREQUENCY OF P53 MUTATIONS OBSERVED IN A DIVERSE COLLECTION OF PRIMARY HEPATOCELLULAR CARCINOMAS

被引:102
作者
BUETOW, KH
SHEFFIELD, VC
ZHU, MH
ZHOU, TL
SHEN, FM
HINO, O
SMITH, M
MCMAHON, BJ
LANIER, AP
LONDON, WT
REDEKER, AG
GOVINDARAJAN, S
机构
[1] SHANGHAI MED UNIV,DEPT EPIDEMIOL,SHANGHAI 200032,PEOPLES R CHINA
[2] ALASKA NATIVE MED CTR,ANCHORAGE,AK 99510
[3] RANCHO LOS AMIGOS MED CTR,DEPT PATHOL,DOWNEY,CA 90242
[4] UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242
[5] JAPANESE FDN CANC RES,INST CANC,DEPT EXPTL PATHOL,TOKYO 170,JAPAN
[6] UNIV CALIF IRVINE,DEPT HUMAN GENET,IRVINE,CA 92717
关键词
D O I
10.1073/pnas.89.20.9622
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent studies of the p53 tumor suppressor locus (designated TP53) in primary hepatocellular carcinoma (PHC) have identified a high frequency of codon 249 mutations. Due to the geographic location from which the samples were obtained and the substitution observed, the mutation was suggested to be attributable to aflatoxin B1 (AFB1) exposure. To determine the generality of this phenomenon, we have examined PHC tissues from 107 geographically and ethnically diverse sources. The frequency of p53 gene mutations was evaluated by using PCR/restriction-digest methods, GC-clamp (G+C-rich sequence) denaturing gradient gel electrophoresis, and DNA sequencing. The mutation rate observed in tumors from high-AFB1-exposure regions (25%) was more than double the rate observed in low-exposure regions (12%) but lower than the 50% frequency previously reported. Codon 249 mutations occurred at a much lower frequency than previously reported (2 of 107 samples examined). These results suggest that changes in DNA encoding p53 may not represent primary oncogenic effects but instead represent genetic changes related to tumor progression. High AFB1 levels may facilitate the generation of these progressional changes, but not by inducing a specific p53 gene mutation at codon 249 as previously reported.
引用
收藏
页码:9622 / 9626
页数:5
相关论文
共 27 条
[1]   CLUSTERING OF HEPATOCELLULAR-CARCINOMA IN ALASKA NATIVE FAMILIES [J].
ALBERTS, SR ;
LANIER, AP ;
MCMAHON, BJ ;
HARPSTER, A ;
BULKOW, LR ;
HEYWARD, WL ;
MURRAY, C .
GENETIC EPIDEMIOLOGY, 1991, 8 (02) :127-139
[2]  
BEASLEY RP, 1981, LANCET, V2, P1129
[3]   SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA [J].
BRESSAC, B ;
KEW, M ;
WANDS, J ;
OZTURK, M .
NATURE, 1991, 350 (6317) :429-431
[4]  
DUBOSE RF, 1990, BIOTECHNIQUES, V8, P271
[5]   BASE SUBSTITUTION MUTATIONS INDUCED BY METABOLICALLY ACTIVATED AFLATOXIN-B1 [J].
FOSTER, PL ;
EISENSTADT, E ;
MILLER, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09) :2695-2698
[6]   THE MOLECULAR-BIOLOGY OF THE HEPATITIS-B VIRUSES [J].
GANEM, D ;
VARMUS, HE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :651-693
[7]  
HARRIS CC, 1990, CANCER CELL-MON REV, V2, P146
[8]   HEPATOCELLULAR-CARCINOMA MUTATION [J].
HAYWARD, NK ;
WALKER, GJ ;
GRAHAM, W ;
COOKSLEY, E .
NATURE, 1991, 352 (6338) :764-764
[9]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[10]  
HOSONO S, 1991, ONCOGENE, V6, P237